Fikret Türkan
Fikret Türkan publishes mostly in Molecular Biology, Organic Chemistry and Pharmacology, on topics such as Enzyme function and inhibition, Cholinesterase and Neurodegenerative Diseases and Synthesis and biological activity.
- World rank
- #327,446 of 7,710,434 ranked researchers
- Rank in Türkiye
- #861 of 117,622
- Works
- 113
- Citations
- 3.7k
- Citations per work
- 32.8
What does Fikret Türkan research?
Fikret Türkan's work is mostly in Biochemistry, Genetics and Molecular Biology (34%), Chemistry (25%), Medicine (19%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences4236.9%
- Physical Sciences3329.4%
- Chemistry2825.1%
- Computer Science54.3%
- Health Sciences2118.9%
- Medicine2118.9%
- Everything else1714.8%
- 1Molecular Biology34% of their works
- 2Organic Chemistry25% of their works
- 3Pharmacology15% of their works
- 4Computational Theory and Mathematics4% of their works
- 5Oncology4% of their works
- 6Plant Science3% of their works
Research topics
- Enzyme function and inhibition
- Cholinesterase and Neurodegenerative Diseases
- Synthesis and biological activity
- Glutathione Transferases and Polymorphisms
- Synthesis and Characterization of Heterocyclic Compounds
- Phenothiazines and Benzothiazines Synthesis and Activities
- Computational Drug Discovery Methods
- Metal complexes synthesis and properties
Which keywords describe Fikret Türkan's research?
The keywords of their largest research topics: Anticancer Agents, Drug Discovery, Toxicology, Drug Development, Carbonic Anhydrases, Inhibitors, Acetylcholinesterase and Cholinesterase Inhibitors.
- Platinum-Based Drugs
- Virtual Screening
- Phenothiazines
- Triazines
- Glutathione Transferases
- Tubulin Inhibitors
- Molecular Docking
- Antimicrobial
- Cholinesterase Inhibitors
- Inhibitors
- Drug Development
- Drug Discovery
- Anticancer Agents
- Toxicology
- Carbonic Anhydrases
- Acetylcholinesterase
- Medicinal Chemistry
- Synthesis
- Heterocyclic Compounds
- Biological Evaluation
- Superoxide Dismutase
- Biological Activities
- Drug Target Identification
- Cisplatin Resistance
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Anticancer Agents1003 topics
- Drug Discovery782 topics
- Toxicology702 topics
- Drug Development592 topics
- Carbonic Anhydrases561 topic
- Inhibitors561 topic
- Acetylcholinesterase481 topic
- Cholinesterase Inhibitors481 topic
- Medicinal Chemistry472 topics
- Antimicrobial372 topics
- Synthesis372 topics
- Molecular Docking362 topics
- Heterocyclic Compounds331 topic
- Tubulin Inhibitors331 topic
- Biological Evaluation221 topic
- Glutathione Transferases221 topic
- Superoxide Dismutase221 topic
- Triazines221 topic
- Biological Activities151 topic
- Phenothiazines151 topic
- Drug Target Identification141 topic
- Virtual Screening141 topic
- Cisplatin Resistance111 topic
- Platinum-Based Drugs111 topic
Where does Fikret Türkan work?
Fikret Türkan's main affiliation in the publication record is Iğdır Üniversitesi, Türkiye.
How many publications and citations does Fikret Türkan have?
OpenAlex counts 113 works and 3,709 citations for Fikret Türkan, an h-index of 37, ranking #327,446 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Fikret Türkan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.